{
  "id": 9053917,
  "title": "Why is AnaptysBio stock rising afterhours today?",
  "url": "https://urgent.news/2026/09/22/why-is-anaptysbio-stock-rising-afterhours-today",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-22T00:57:29.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/stock-market-news/why-is-anaptysbio-stock-rising-afterhours-today-93CH-4909804"
  },
  "original_language": "en",
  "account": "AnaptysBio Inc stock increased by 3.8% in after-hours trading following the company's announcement of positive second-quarter and transitional fiscal year 2026 financial results. The San Diego-based biotech firm reported revenue of $27.5 million, which exceeded expectations by more than 36%, surpassing the estimated $20 million. CEO Daniel Faga expressed optimism regarding the company's future prospects, citing potential near-term value catalysts in his earnings release. These catalysts include accelerated sales of Jemperli outside the U.S., an expected FDA approval of Jemperli as a monotherapy for a specific type of rectal cancer, a looming litigation judgment against GSK and Tesaro, and a projected FDA approval of Quimilza in a specific condition by December 2026. The positive market sentiment also contributed to the stock's rise, as Wall Street experienced a surge earlier in the week, bolstered by the performance of tech shares.",
  "summary": null,
  "key_points": [
    "AnaptysBio reported $27.5M revenue, exceeding expectations by 36%",
    "CEO Daniel Faga sees near-term value catalysts in Jemperli sales and FDA approvals",
    "Market sentiment and tech shares' performance boosted stock rise"
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}